Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: HSIC

Henry Schein, Inc.

Healthcare | Medical - Distribution
$77.54 +0.00 (+0.00%) as of 2026-07-15 02:06 UTC
Market Cap$9.0B
EPS (TTM)$3.27

Henry Schein, Inc. (NASDAQ: HSIC) is a $9.0B medical - distribution company trading at $77.54 — 23.7× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:06 UTC.

52-Week Range
Low $74.18High $81.06

What Henry Schein, Inc. does

Henry Schein is a health care solutions company that distributes dental and medical products and services to office-based practitioners and alternate care settings worldwide. The company serves more than one million customers across dental practices, physician offices, laboratories, and other health care facilities through a global network of distribution centers and manufacturing facilities. Its business operates through three segments: distribution and value-added services, specialty products manufacturing, and practice management technology.

Summarized from Henry Schein, Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$77.54
Change (1D)+0.00 (+0.00%)
Market cap$9.0B
52-week range$74.18 – $81.06
Valuation
P/E (TTM)23.71×
EV/EBITDA10.10×
EPS (TTM)$3.27
Price/book2.30×
Return on equity10.21%
Debt/equity0.20
Returns
52-week return+4.5%
Revenue, margins & earnings
FY2021 Net income: $631MFY2021 Taxes & interest: $221MFY2021 Operating expenses: $2.82BFY2021 Cost of revenue: $8.73B$12.4BFY2021FY2022 Net income: $538MFY2022 Taxes & interest: $209MFY2022 Operating expenses: $3.08BFY2022 Cost of revenue: $8.82B$12.6BFY2022FY2023 Net income: $416MFY2023 Taxes & interest: $199MFY2023 Operating expenses: $3.25BFY2023 Cost of revenue: $8.48B$12.3BFY2023FY2024 Net income: $390MFY2024 Taxes & interest: $231MFY2024 Operating expenses: $3.40BFY2024 Cost of revenue: $8.66B$12.7BFY2024FY2025 Net income: $398MFY2025 Taxes & interest: $255MFY2025 Operating expenses: $3.45BFY2025 Cost of revenue: $9.08B$13.2BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-15
  • 2026-06-15DANIEL WILLIAM KA2,215—
  • 2026-05-26BERGMAN STANLEY MG-50—
  • 2026-05-22BERGMAN STANLEY MG-50—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • Kohlberg Kravis Roberts & Co. L.P.15,652,032$1.15B0.0%
  • VANGUARD GROUP INC11,257,926$850.87M-6.2%
  • Artisan Partners Limited Partnership6,573,023$484.43M-1.1%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Henry Schein, Inc. do?

Henry Schein is a health care solutions company that distributes dental and medical products and services to office-based practitioners and alternate care settings worldwide.

What is HSIC's valuation?

HSIC trades at $77.54, 23.71× trailing earnings, 10.10× EV/EBITDA, as of 2026-07-15.

When did HSIC last file with the SEC?

Henry Schein, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-22. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:06 UTC. This page is also available as JSON at /api/data?ticker=HSIC and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for HSIC and 3,500+ tickers.

Create a free account — keep HSIC
For your agent
GET /api/data?ticker=HSIC

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt